Stay updated on Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial page.

Latest updates to the Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial page
- Check5 days agoChange DetectedFooter updates were made. The HHS Vulnerability Disclosure link was removed and a new Revision: v3.3.3 was added, while Revision: v3.3.2 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 added to the history and revision: v3.3.1 removed.SummaryDifference0.1%

- Check34 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1. No substantive changes to the study record or its public presentation are visible.SummaryDifference0.1%

- Check41 days agoChange DetectedThe top banner about government funding and operating status has been removed; this banner did not affect study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check55 days agoChange DetectedThe page's visuals were refreshed with updated spacing and layout in the Record History section, with no new data or study details added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now includes a government-funding lapse notice and a new version tag (v3.2.0), replacing the previous v3.1.0; users should refer to official sources for operating status.SummaryDifference10%

Stay in the know with updates to Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial page.